In the news

Genetically engineering a treatment for incurable brain tumors

Glioblastomas are almost always lethal. Traditional treatment methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective. A team of Purdue researchers, led by cancer institute member Sandro Matosevic, is developing a patent-pending treatment.

First annual PICR Awards ceremony recognizes excellence in cancer research

In a significant milestone for the Purdue Institute for Cancer Research (PICR), faculty, students and staff gathered at the Hansen Life Sciences Research Building on April 17 to honor seven awardees for their outstanding contributions to cancer research.

Yoon Yeo and team create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy

Immunotherapy is a promising approach to fighting cancer. A team led by Yoon Yeo of the Purdue Institute for Cancer Research, Purdue University College of Pharmacy, and Purdue Institute for Drug Discovery, is developing nanoparticles to make it even better. These innovative researchers are developing and validating patent-pending nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.

Low to be honored by American Lung Association for cancer-fighting invention

The American Lung Association in Indiana will honor Purdue University researcher Philip Low on April 13 at its annual gala in Indianapolis for his invention of CYTALUX, which helps in the fight against lung cancer.

Pamala Morris named associate director of inclusive excellence

The Purdue Institute for Cancer Research (PICR) is excited to announce the appointment of Pamala Morris as its first associate director of inclusive excellence.

February 9, 2024

Cancer institute researchers edge closer to delivering personalized medicine to cancer patients

For the first time, Purdue researchers prove that measuring mechanical motions in living cancer tissues is a viable and promising approach for predicting chemoresistance.

January 13, 2024

Mesecar Purdue cancer institute directorship supported with $5 million Walther gift

Andrew Mesecar, recently ratified by the Purdue University Board of Trustees as the Robert Wallace Miller Director of the Purdue Institute for Cancer Research (PICR), will be supported in the role by the Walther Cancer Foundation Director’s Fund, a $5 million gift from the Walther Cancer Foundation.

January 3, 2024

Exposure to cigarette smoke increases cancer risk in dogs

A long-term study following Scottish terriers indicates cigarette smoke exposure leads to a sixfold increase in the risk of bladder cancer

December 4, 2023

Discovery points to new approach to treating liver cancer

Boosting levels of a naturally occurring enzyme could improve the effectiveness of the liver cancer drug sorafenib.

November 14, 2023

Purdue pharmaceutical compound sounds the alarm on cancer cells and unleashes T cells

Zhong-Yin Zhang of Purdue University’s College of Pharmacy and the Purdue Institute for Drug Discovery leads a team that has created a novel cancer immunotherapy compound that degrades an enzyme found in cancer cells and T cells. The research was published in the Royal Society of Chemistry’s peer-reviewed journal Chemical Science.